Understanding modern ulcerative colitis through real-world data
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists...
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Real-world evidence (RWE) studies often stall on the same friction points: defining the most...
Veterans Day invites us to look beyond branch and rank to the people and stories behind the...
Alzheimer’s disease burden and the current therapy pipeline Alzheimer’s disease remains the leading...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
Artificial intelligence is moving quickly into healthcare research, but one question still comes up: can you trust it? If an AI platform is going to support study design, cohort definition, analysis and reporting, RWE teams need confidence that the o...